Chronic manganism. Neurologic and laboratory studies during treatment with levodopa.
D000284:Administration, Oral; D000328:Adult; D002908:Chronic Disease; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000627:therapeutic use*; D004492:Edetic Acid; D005149:Facial Expression; D006197:Hair / Q000032:analysis; D006801:Humans; D008297:Male; D008345:Manganese / Q000097:blood / Q000652:urine; D020149:Manganese Poisoning; D008875:Middle Aged; D009461:Neurologic Manifestations; D009784:Occupational Diseases / Q000139:chemically induced; D011041:Poisoning / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D011596:Psychomotor Disorders / Q000209:etiology; D012026:Reflex, Stretch; D012535:Scalp; D013057:Spectrum Analysis; D013909:Thorax; D014202:Tremor / Q000209:etiology
D008345:Manganese; D004295:Dihydroxyphenylalanine; D004492:Edetic Acid